Protelight Pharmaceuticals

Focus: Protelight Pharmaceuticals is a China-based pharmaceutical company specializing in peptide and small molecule therapies, currently focused on early-stage development in neurology and infectious disease indications.

Neurology

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Protelight Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow Protelight Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories

Colpomycosis

Phase 1

Clinical Trials (1)

NCT05340790First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories

Phase 1

Help build intelligence for Protelight Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to contribute to novel antimicrobial peptide technology with two active clinical programs addressing unmet needs in diabetic foot ulcers and colpomycosis
Ground-floor role at an early-stage company with potential for rapid career progression and broad responsibility ownership
China-based biotech with potential access to emerging market opportunities and cost-efficient R&D infrastructure

Watch Out For

Extremely early-stage pipeline with only one Phase 1 trial active and no Phase 3 programs—minimal near-term clinical validation or revenue catalysts
Zero current hiring activity (0 open positions) and no disclosed funding, financial metrics, or employee count raises questions about runway and growth capacity
No published scientific output, clinical trial activity, or disclosed milestones limits visibility into scientific credibility and execution capability

Generated by Claude from Protelight Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Antimicrobial Peptide PL-5 Topical Spray and Placebo

Diabetic Foot Ulcers

Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo